Top Markets
#1 Black Phoenix Black Phoenix +831.35%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +29.79%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.50%
#4 Beam Beam +26.38%
#5 SAFEcoin SAFEcoin +20.76%
#6 Magma Finance Magma Finance +20.25%
#7 pipedog pipedog +19.56%
#8 PondCoin PondCoin +18.82%
#9 THORChain THORChain +16.58%
#10 Bless Bless +16.25%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Nanobiotix S.A. Nanobiotix S.A.

Nanobiotix S.A.

NANO
Rang in Aktien #5949
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Aktienkurs
$45.79
Marktkapitalisierung
$2.33B
Veränderung (1 Tag)
11.43%
Veränderung (1 Jahr)
408.10%
Land
FR
Handel Nanobiotix S.A. (NANO)

Kategorie

Healthcare
Kursverlauf für Nanobiotix S.A. (NANO)
Höchster Schlusskurs: $41.65 am 2026-08-01

Niedrigster Schlusskurs: $8.60 am 2012-10-01
Kursverlauf der Aktie von Nanobiotix S.A. von 2012 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 29.51%
2025 582.51%
2024 -45.85%
2023 51.22%
2022 -50.99%
2021 -50.84%
2020 93.52%
2019 -37.58%
2018 -11.94%
2017 -7.30%
2016 -2.69%
2015 -15.40%
2014 172.96%
2013 -14.45%
2012 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.14 40.88%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.84%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $142.44 467.49%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH